Skip to content

Dr. Silke STEYAERT

Active
Private limited companyfounded 2021active for 4 yearsElzasstraat 22, 3040 Huldenberg, BelgiumKBO/BCE: BE 0778.847.939
Summary

Dr. Silke STEYAERT has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,628 and a net result of €41,132. Equity has been shrinking by about 41% per year since 2022. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 6% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-12-2021 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.325.484.730 3040 Huldenberg, since 20-12-2021
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • Steyaert SilkeDirector

Financial position

90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€72,217
▲ 259%
Turnover
≈ €160,000
estimated
Profit
€41,132
Equity
€4,628
▼ 90.5%
Total assets
€319,983
▲ 4.0%
Score breakdownraises riskEquity €4,628 (1.4% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €319,983Liquidity: current ratio 0.53, cash €66,614Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 20% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 26-15
equity 1.4% of total assets
Liquidity 56-2
short-term debt 41.5% · cash 20.8%
Profitability 85+54
return on assets 12.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026highest value 04-2026: < 0.1%▼ -0.1 percentage points vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 6% of them on solvency, 32% on liquidity, 35% on profitability and 5% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €319,983
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €4,628 (1.4% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.53, cash €66,614
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 6%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-03-2026, 135 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
135 days early
2024
26 days late
2023
28 days late
2022
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 20 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 August (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 94% of companies in human healthsector median 63.0% · 20,700 companies 1.4% View
  • Positive: Back in profit in 2025after a loss of €25,379 in 2024 €41,132 View

Recent changes

  1. · Gazette deed Incorporation
All 7 events

Comparable companies

These companies have the same main activity as Dr. Silke STEYAERT: general medical practice (NACE 86210). They are comparable in size and age: total assets between €285,000 and €335,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Dr. Silke STEYAERT Huldenberg€319,983€72,217
YUNION Merchtem€334,573€81,313
DOCTEUR MARIE HONHON Blégny€330,514€76,450
Docteur Marika Toniolo, pédiatre Dinant€302,630€79,563
DOKTER WILLEM DELRUE, HUISARTS Anderlecht€285,029€77,079
Dr. Van Den Abeele Sofie Oudenaarde€306,584€64,986
CABINET MEDICAL NOEMIE GOUBLOMME Farciennes€310,915€75,760
Full comparison

Key facts about Dr. Silke STEYAERT

What is the company number of Dr. Silke STEYAERT?
The company number of Dr. Silke STEYAERT is 0778.847.939. The VAT number is the same number with BE in front: BE 0778.847.939.
Where is Dr. Silke STEYAERT based?
The registered office is at Elzasstraat 22, 3040 Huldenberg.Company details
What does Dr. Silke STEYAERT do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Silke STEYAERT?
The legal form of Dr. Silke STEYAERT is Private limited company (BV).
When was Dr. Silke STEYAERT founded?
Dr. Silke STEYAERT was founded on 20-12-2021.
Is Dr. Silke STEYAERT still active?
Yes, Dr. Silke STEYAERT is an active enterprise in the KBO register.
What is the turnover of Dr. Silke STEYAERT?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €72,217 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €210,000.Financials
Is Dr. Silke STEYAERT profitable?
In financial year 2025, Dr. Silke STEYAERT made a profit of €41,132.
Where can I find the annual accounts of Dr. Silke STEYAERT?
Dr. Silke STEYAERT filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Silke STEYAERT due?
Dr. Silke STEYAERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.